Non-profit life sciences incubator Massachusetts Biomedical Initiatives (MBI) announced that three new companies joined its ...

We speak with a member of BioProcess International's editorial advisory board about the link between friendship and business.

But before we say goodbye to 2025, we leave you with five of our favorite features from this year, delving deeper into a few ...

BPI contributor Justin Byers is cofounder and chief executive officer of Axio BioPharma.

Cell-line development enhances biopharmaceutical production capacity and quality, but complex biologics like bsAbs and ADCs present new challenges.

Biotechnology company Leucid Bio announced a strategic collaboration with Syenex, an open-source gene therapy platform firm.

Authors explore complexities in scaling gene-therapy production with special attention is to monitoring and enhancing ...

A new clinical trial has shown promising safety and efficacy results for liraglutide in the treatment of Alzheimer’s disease.

The company is struggling to make ends meet as it loses a major undisclosed client.

Last week, UK-based pharmaceutical conglomerate AstraZeneca announced a further $2 billion investment at two separate sites within the US state of Maryland. This follows an overarching pledge of $50 ...